Breaking Ground in Prostate Cancer: BriaCell Announces Lead
Bria-Pros+ is based on BriaCell’s next generation personalized immunotherapy platformBria-Pros+ is capable of activating multiple types of immune cells,...
Stay updated with breaking news from Williamv Williams. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bria-Pros+ is based on BriaCell’s next generation personalized immunotherapy platformBria-Pros+ is capable of activating multiple types of immune cells,...
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) (“BriaCell”...
Significant reduction of metastatic breast cancer tumor behind-the-eye after only 3 cyclesPowerful anti-tumor response associated with reduction in...
Median overall survival of 13.4 months in patients treated with the Bria-IMT™ combination regimen (vs. 6.7-9.8 months for similar patients reported in the literature*).32 out of 42 patients treated since 2022
PHILADELPHIA, Pa. and VANCOUVER, British Columbia, Oct. 04, 2023 -- BriaCell Therapeutics Corp. , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer...